Purpose of this Study
We are doing this study to find out the most preferred method among lung cancer patients for being connected to remote patient monitoring (RPM) devices. RPM devices are instruments that a patient can use to measure their own weight and vital signs. We want to find out if patients have an easier, more efficient time setting up these devices by using a virtual interface or with the assistance of a human agent.
Who Can Participate?
Eligibility
Adults ages 18+ who:
- Are diagnosed with lung cancer
- Are scheduled to visit the Duke Cancer Center for appointments at least 3 days in a row
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Description
If you choose to join this study, you will get a random assignment (like a coin flip) to learn about your RPM device through either a virtual agent or a human agent. Your participation will last for 3 days and will include assessments of your medical/oncological history, performance status, body measurements, and vital signs. You will complete onboarding over the phone with the agent you are assigned to and measure your own weight and vital signs with the RPM devices. You will also fill out surveys about your experience.
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
A randomized pilot study comparing the feasibility of using a virtual agent vs. an off-site human agent to onboard oncology patients to a remote monitoring device
Principal Investigator
Laura
Alder
Protocol Number
PRO00116186
NCT ID
NCT06682013
Phase
Pilot
Enrollment Status
Pending Open to Enrollment